MSB 7.69% $1.19 mesoblast limited

Ann: Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease, page-138

  1. 921 Posts.
    lightbulb Created with Sketch. 73
    I’ve been waiting for donkeys years for the “revolution in medicine.”
    My hair was black when I first held MSB shares, now gray.

    The only news that will come out is “FDA in shutdown cos of COVID-19”



 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.